Minerva Biotechnologies

Cell Signaling Technologies, based in Beverly, MA, is recognized globally for its extensive range of high-quality antibodies and related research products, serving the life sciences community for over 25 years. The company's product offerings include primary and secondary antibodies, ELISA kits, cellular assay kits, and an array of reagents and comprehensive solutions tailored for various applications including cancer research, immunology, and neuroscience. With a commitment to reliability and validation, Cell Signaling Technologies provides leading-edge solutions for research through robust assay platforms and continuous supply of essential products. Their dedication to environmental and social responsibility further underscores their role as a trusted partner in advancing scientific discovery. Generated from the website

Cambridge Chemical Technologies, based in Cambridge, MA, is a technology-driven process engineering firm specializing in chemicals, petrochemicals, and alternative energy technologies. The company offers tailored services in process technology definition, commercialization, technology transfer, and basic engineering to ensure streamlined and cost-efficient project execution. Recognized for their expertise in fluid bed reactor design, CCTI engineers apply advanced technologies that are operational worldwide. They provide clients with individualized roadmaps for commercializing new technologies, bridging technical and commercial knowledge gaps while identifying and mitigating risks to enhance their clients' technical strengths. Generated from the website

Quiver Bioscience, formerly known as Q-State Biosciences, is a leading biotechnology company based in Cambridge, MA, dedicated to revolutionizing drug development for neurological diseases. With a decade of scientific advancements and cutting-edge technology, Quiver utilizes human disease models, artificial intelligence, and a state-of-the-art platform to discover and develop transformative medicines for patients living with brain disorders. Driven by their innovative approach, Quiver integrates scalable biology, advanced engineering, and surrogate models to identify novel therapeutic targets and candidate molecules. Their proprietary cellular models capture the complexities of human biology, while their lineup of technologies and instrumentation measures hundreds of properties associated with cellular function per neuron. Through their analytics algorithms, Quiver extracts data from individual cells to gain insights into disease states and optimize therapeutic candidates with greater translational potential.Generated from the website